Overview Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes Status: Completed Trial end date: 2017-05-11 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy, safety, and tolerability of ISIS-GCGRRx in combination with metformin versus placebo Phase: Phase 2 Details Lead Sponsor: Ionis Pharmaceuticals, Inc.